Osteosarcoma — Trials

Osteosarcoma — Trials · CancerIndex

Clinical trials

Registered studies

349 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 99
Recruiting: 58
Ph III recruiting: 2
Growth YoY: —
Industry share: 14%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (40)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06935409	Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure	active not recruiting	Phase 3	117	Hansoh BioMedical R&D CompanyINDUSTRY	1	Apr 9, 2026	clinicaltrials

Data updated 22 days agoSource updated Apr 9, 2026source: clinicaltrials